For the research, Which? conducted an online poll of 1,009 pet owners who had had an issue with their vet in the past two years.
It also conducted qualitative interviews with 14 owners who had complained.
The most common reasons for complaint were:
Of the 1009 pet owners who had experienced some kind of problem with their vet, 57% did NOT make a complaint, 33% because they did not want to fall out with their vet.
Pet owners who wish to complain about veterinary services have three options: to complain directly to their practice, to use the voluntary Vet Client Mediation Service (VCMS), or to raise a 'concern' with the RCVS.
The Which? report found that of those who did complain to their practice, 35% were not happy with the outcome and 31% with the way it was handled.
Which? found that although the VCMS reported a high resolution rate of 84% in 2022-23, its interviewees had found it a bit hit or miss.
Finally, Which? found the process of complaining to the regulator flawed by the fact that the threshold for the College to progress a 'concern' is set so high, because College has no jurisdiction at a practice level, and because it has no sanctions to use in enforcing consumer law.
The report recommends that:
Full report: https://www.which.co.uk/policy-and-insight/article/complaints-and-redress-in-veterinary-services-a5z611X9tZzf
CommentI loved the regal response from the RCVS to The Guardian about the case studies in the Which? report: “the facts presented in the case studies do not completely align with those reported to us”.
That aside, surely the big issue here is not so much that consumers have little way to complain effectively.
That is important, of course, but isn't it more important to consider what they are complaining about, which in the main is MONEY.
Driven by the advances in veterinary medicine, the innate desire of vets to provide the best possible care, anthropomorphising pet owners saying they want 'the best' for their fur baby (without necessarily having the wherewithal), corporatisation and society's changing expectations about working conditions, prices have been going up at a rate far outstripping inflation.
Increasing prices have of course been accompanied by an increase the standards of care and the range of clinical equipment.
But the question everyone must ask is at what point the cost of veterinary care for a dog outstrips the benefits of owning one?
These complaints are the canary in the coalmine.
The Alliance to Save Our Antibiotics is urging the Prime Minister to make the announcement on antimicrobial resistance he promised the House of Commons during Prime Minister's Questions on Wednesday 7th May 2014.
In a reply to a question from Zac Goldsmith MP, David Cameron acknowledged that the problem of antibiotic resistance could have 'unbelievably bad consequences' leading to quite minor ailments not being properly treatable by antibiotics. The Alliance is urging the government to take urgent action to reduce antibiotic use in both medicine and farming.
The issue was further highlighted at this year's World Health Assembly (WHA) Conference when attendees confirmed that a catastrophic post-antibiotic age - in which minor, common infections could again become killers - is a real possibility unless urgent action is taken.
At the conference, the Netherlands' Minister of Health, Edith Schippers said: "People are getting seriously ill and are dying as a result of skin infections and diarrhoea. Common surgeries like knee replacement will become potential killers because of secondary infections that are untreatable. This is a global problem on a par with, if not more serious than, nuclear security, international terrorism and climate change."'
In a letter to David Cameron on 13th May 2014, the Alliance to Save Our Antibiotics said: "It simply does not make sense to be feeding nearly half of all the antibiotics used in this country to farm animals, just so that they can be kept in high numbers indoors, often in conditions which carry with them the risk of high levels of disease."
The Alliance says the measures the Prime Minister is due to announce must include the urgent phase-out of the routine preventative use of antibiotics in farming.
Alison Craig, Campaign Manager for the Alliance to Save Our Antibiotics said: "Our near European neighbour the Netherlands has phased out routine preventative use of antibiotics in farming by government taking strong and decisive action and industry taking voluntary measures - so why can't we do the same in the UK?"
In 2007 the Netherlands was one of the world's heaviest users of antibiotics in food animals. In 2009 the government decided to decrease farm use of antibiotics by 50%. This was achieved by 2013.
Alison continued: "It is alarming that, in this country, we don't even yet know how many people are already dying due to antimicrobial resistance. By contrast, in the Netherlands they know that there are 2 million hospitalisations per year due to resistance.
"If the Prime Minister knows that there will be 'unbelievably bad consequences' for families, why is his government being so slow about getting a grip on the problem?"
Pedigree® today launched its 2009 Pedigree Adoption DriveTM to highlight the issue of dog abandonment in the UK.
It's estimated that there are 100,000 abandoned or stray dogs in the UK every year. Pedigree surveyed animal rescue homes across the UK and in just 33 centres, found that over the course of just eight days between Christmas and New Year, an average of 12 dogs were abandoned per centre, equalling more than one every day.
Clarissa Baldwin, Chair of the Association of Dogs and Cats Homes (ADCH) comments: ‘These statistics illustrate the severity of the situation. As a nation of so-called dog lovers, it is unacceptable that pets are being treated as throwaway commodities. Dog ownership is a privilege, not a right.'
Jane Bingham, Pedigree Adoption Drive Manager said ‘We are saddened by the alarming number of dogs being abandoned each year. Our aim is to help raise awareness of the issue of dog abandonment to ensure that re-homing centres are given support to enable them to continue their wonderful work.
‘The rewards pets provide to responsible dog owners are evident yet the figures show there are still thousands of dogs who are in need of loving homes.'
Pedigree's research has found that over seven million dog owners state that their dog makes them happier and over 1 in 4 (nearly three million dog owners) actually admit they love their dog more than some members of their own family!
The Pedigree Adoption Drive aims to not only increase the public's awareness of dog abandonment, but also to raise funds to help rescue centres and charities across the UK re-home these dogs. Now in its second year, The Pedigree Adoption Drive is aiming to increase monies donated from last year's £489,000 to £600,000 by donating 2p for every single Pedigree product sold during January and February 2009.
For more information visit The Pedigree Adoption Drive website - http://www.pedigreeadoptiondrive.com./
There are three full equine streams running for the duration of the two days, programmed by the Royal Veterinary College and the British Veterinary Association in partnership with the British Equine Veterinary Association. Organisers say the programme has been designed to ensure it caters for both mixed and equine only veterinary surgeons.
The lecture streams are complemented by the show’s ‘Meet the Professor’ equine sessions, where a number of the speakers are able to have more intimate discussions with a smaller group of delegates.
Topics covered in the 36 sessions include:
For more information on the BVA/BEVA Equine Theatre, RVC Equine Theatre 1 and RVC Equine Theatre 2 programmes at the London Vet Show or to register for the event visit londonvetshow.co.uk.
The Targets Task Force comprises a leading veterinary surgeon and farmer from each of the beef, dairy, egg, fish, gamebird, pig, poultry meat and sheep sectors, who have been consulting with key organisations in their respective industries. The group also includes observers from regulators Food Standards Agency and Veterinary Medicines Directorate (VMD).
While the targets each sector has set vary according to the availability of data and scope in their sector, the targets as a whole have been described as 'positive and proactive' by the VMD.
The headline targets for the eight sectors include a reduction in use of antibiotics in pigs by over 60% between 2015 and 2020, with minimal use of highest priority Critically Important Antibiotics (CIAs). RUMA reports that good progress has already been made in this sector, with usage falling by around 35% between 2015 and 2016.
Targets Task Force member and president of the Pig Veterinary Society Mark White said: "It's encouraging to see the response in the sector to the challenge laid down, which bodes well for achieving our ambitious 2020 goal. It is evident that the sector – steered mainly by the members of the Pig Veterinary Society, AHDB Pork and the National Pig Association – has the will and the capability to fully engage with the issue."
Next steps, he said, were to focus on eliminating routine preventative treatment where it is still happening, mainly due to lack of resource or expertise. "We can also work to improve water delivery systems so that more targeted treatment in the water can be used instead of in-feed medication."
The dairy cattle sector has committed to a 20% reduction by 2020, with a particular focus on halving use of the highest priority CIAs. The work to achieve this will be led by a newly-created Dairy Antimicrobial Stewardship Group (DASG) which includes all key organisations in the sector.
Some of the strategies to achieve these goals in dairy farming include reducing the use of antibiotic dry cow therapy and injectable products, and cutting back on group treatments such as antibiotic footbaths for lameness which remain largely unproven, instead using topical and targeted treatments.
Di Wastenage, dairy farmer from Devon, Task Force member and chair of the DASG, said the sector needed to be ambitious about what it could achieve. “While use is lower than in some sectors, there are clear areas to tackle where use can be habitual, or common disease problems go unchallenged.
"For example, eliminating BVD and Persistently Infected animals from the herd is one of the obvious places to start, as well as talking to your vet to calculate the usage levels you have at the moment. Calf rearing can produce a 'hot spot' of treatment, as can digital dermatitis. Everyone has the potential to use antibiotics more responsibly somewhere."
The gamebird sector, having undergone a comprehensive awareness-raising initiative among game rearers in 2017 to cut back on reducing the need for medicines, aims to reduce use by a quarter this year, with a further 25% reduction between 2018 and 2020.
Three sectors – poultry meat, laying hen and fish – are either already low users of medicines or have made significant reductions over the past five years. These sectors will be focusing on maintaining use at the minimal level needed to ensure good health and welfare among their livestock, while tackling emerging challenges should they arise.
The poultry meat sector, previously described as a 'pathfinder' for the rest of the farming industry, has already reduced use by 71% between 2012, when its stewardship scheme was introduced, and 2016.
In doing this, the poultry meat sector has also ceased all preventative treatment and use of the highest priority CIAs. It will now maintain current levels in chickens and look for further reductions in turkeys. This sector will use clinical governance to ensure CIA antibiotics are only prescribed when absolutely needed and with sign off from veterinary specialists and management.
The laying hen and fish sectors have similarly committed to continuing low use, with the laying hen sector eliminating all use of highest priority CIAs in the past two years. The development of a vaccine in the salmon sector several years ago successfully controlled one of its most challenging bacterial diseases, so the focus has turned to the health of the ‘cleaner fish’ used to provide natural control of sea lice.
The trout farming sector, with its greater number of small producers, is concentrating on reducing the need for antibiotics and improving data capture.
The beef and sheep sectors are already low users of antibiotics, but have acknowledged they each need better data, and will also commit to addressing 'hotspots' of use. Both have committed to a 10% reduction in antibiotic use by 2020, subject to securing better data.
For the beef sector, reduction in use centres around calves and youngstock, particularly in the areas of respiratory disease. There is also an emphasis on calves from dairy herds, where mixing animals from different sources can create a peak in disease pressure similar to children going to school for the first time.
In sheep, the focus areas are to reduce routine preventative antibiotic usage against abortion (miscarriage), lameness and neonatal lamb diseases such as watery mouth and joint ill.
With initiatives proving that routine preventative use is largely avoidable through a combination of vaccination, good hygiene, quality nutrition and careful shepherding, Dr Fiona Lovatt of the Targets Task Force is optimistic about the opportunities to reduce overall use.
"In the sheep sector, we’re not high users of antibiotics. But we want to ensure that any use is totally targeted so we are challenging all inappropriate or routine preventative use.
"Convincing farmers to change practices is tricky, and none of us want to see an increase in levels of disease, but those who have had the courage to work with their vets to change what they do are now seeing what is possible. The answer is to take a holistic approach and work closely with a keen sheep vet."
Gwyn Jones, chair of both RUMA and the Targets Task Force, said he has been overwhelmed by the positivity of the group and its willingness to be ambitious. "The members have worked very hard and have shown incredible leadership and persistence. They have also provided unprecedented support and inspiration to each other.
"I am delighted they have agreed that the group should continue to meet twice-yearly to review progress and discuss issues."
The full report with all targets for each sector can be downloaded from the RUMA website www.ruma.org.uk.
Veterinary surgeons who want to pay in full must do so before before 1st June 2021. For those UK-practising vets who want to pay the fee in three instalments, the first payment should be received before 1st June, the second payment before 1st October and the final payment before the end of the year.
Any vets who do not pay either the fee in full or the first instalment before 1st June will be removed from the Register. If they want to be restored, they'll need to pay an additional restoration fee as well as the registration fee.
Professor Susan Dawson, RCVS Treasurer, said: “Due to the ongoing disruption to the profession because of the lockdown, we are glad to say that RCVS Council has again approved the ability for members of the profession to pay their fee in instalments and therefore spread the cost during this already difficult year.
"We would like to remind members of the profession that the option to pay in instalments is only available to UK-practising veterinary surgeons. For any UK-practising veterinary surgeons who have a Direct Debit set up but who wish to pay by instalments, please make sure to cancel your Direct Debit as soon as possible."
Payments can be made via the My Account area of the RCVS website (www.rcvs.org.uk/myaccount) where you will also need to confirm that you meet the annual continuing professional development (CPD) requirement and declare any convictions, cautions and/or adverse findings.
Any questions, contact the Registration Department: registration@rcvs.org.uk or 020 7202 0707.
For advice about making payments or submitting a remittance form, contact the Finance Department on finance@rcvs.org.uk or 020 7202 0723.
Further details about paying in instalments can also be found in a series of FAQs at: www.rcvs.org.uk/setting-standards/advice-and-guidance/coronavirus-covid-19/retention-fee-faqs/
Founder Jade Statt said: "As StreetVet grows, we are being contacted to help clients outwith our current active StreetVet locations, of which there are now 13. For this reason and to help us continue to expand, we would like to put out a call to the profession to ask any practices that are happy to work with us to get in touch and help us set up a StreetVet Directory of Supporting Practices."
If you'd like to know more about partnering with StreetVet, email: StreetVet.practices@gmail.com
You'll be sent detailed information about the options for working with StreetVet and offered a fundraising pack. If you go ahead, you'll also have your practice logo added to a directory on the StreetVet website.
Novartis Animal Health Inc. has completed an agreement with Luitpold Pharmaceuticals, Inc. that grants marketing rights for Adequan® Equine to Novartis in all major equine markets outside the U.S. The first launch of Adequan® Equine by Novartis will take place in Canada in June.
Adequan® Equine is indicated for treating joint dysfunction and lameness in horses caused by injury or degenerative problems. It is available for intramuscular and intra-articular administration. Adequan® is also indicated for treating joint dysfunction and lameness caused by injury or degenerative problems in dogs.
Mickey McDermott from Novartis' Communications Dept told VetSurgeon that the timing of Adequan's arrival in the UK depends on how long it takes to complete the registration transfers, but that the company hopes it'll be before the end of the year.
Together, they're producing an educational video to be distributed and used by registered career advisers across the Southwest of England, and subsequently across the rest of England.
Remi qualified from the Royal Veterinary College in London as a registered veterinary nurse in 2019 and then applied to start the graduate Veterinary Medicine programme at the same university.
She said: “I didn’t quite get the grades to study to be a vet straight away, but I always knew that I wanted to focus on a surgical career path and having gone through the university application twice, I want to help other students realise that they too can pursue a career as a vet or vet nurse.
“I met the managing director of JHP Recruitment, Justin Powlesland, at a networking event and explained how keen I was to help more people realise that there is more than one way to become a veterinary professional and to encourage school age children not to dismiss a veterinary career from an early age.
Justin said: “We have employed a production company and are now looking for a location to film it.
"Ideally, we need a teaching hospital to offer us some space for a day, as we want to set our interview with Remi in a clinical setting, where there is plenty of equipment to see.
"We are hoping to film this summer and are appealing for help to find a location.
“The video will tell Remi’s story about the hurdles she has faced and overcome to ultimately study to become a vet, it will also show students where the veterinary industry can take them and the different roles and routes to study that are available.
"As well as the video, a downloadable PDF version will be created, which are both great resources for career advisers that we will also share across social media.”
Remi added: “I really hope that what we are doing will encourage more people from diverse backgrounds to consider going to into higher education to start a career in veterinary medicine or veterinary nursing – that’s the ultimate goal.”
Any teaching hospital that can help with a filming location is being asked to contact Justin via email Justin@jhprecruitment.com or to call him on 07506 981 354.
However, the attainment of clinical remission did reduce the likelihood of subsequent death due to gastrointestinal disease.
In the study titled “Outcome of chronic inflammatory enteropathy in cats: 65 cases (2011-2021)”1, cats diagnosed with chronic inflammatory enteropathy were retrospectively identified from three medical records databases, and follow-up information obtained from the referring veterinary surgeon.
This information was used to determine if clinicopathological variables were associated with death due to gastrointestinal disease in diagnosed cats.
Sixty-five cats with chronic inflammatory enteropathy were included in the study, with follow-up information available for 54 cats (83%).
Of these, 37% (n=20) were euthanised due to gastrointestinal disease and 46% (n=25) were alive and in clinical remission, with 64% (n=16) of these diagnosed with food-responsive enteropathy.
The study did not find a correlation between the tested clinicopathological variables, measured at the time of histopathological diagnosis, and death due to gastrointestinal disease, or length of survival in these cats before death due to gastrointestinal disease.
This, the authors say, suggests that alternative diagnostic measures should be identified to definitively investigate outcome and survival in cats with chronic inflammatory enteropathy.
The study also adds weight to previous research which recommends the use of therapeutic diets in cats with chronic inflammatory enteropathy, although further research is needed to clarify a favourable treatment protocol.
First author, Dr Yuvani Bandara, said: “Knowledge that the attainment of clinical remission reduces the likelihood of subsequent death due to feline chronic inflammatory enteropathy is important for veterinary surgeons and owners.
"We hope that our findings can act as a foundation for further research to investigate factors that support the attainment of clinical remission in affected cats.
"Thank you to BSAVA PetSavers for funding this study.”
Reference
Conducted as a multicentric international study involving board-certified veterinary dermatologists, the trial included 35 dogs with CIF in at least two paws.
Each dog acted as its own control, and was treated with systemic antibiotics, with one paw being treated with FLE and the other paw without.
Paws were allocated based on a coin toss, and the study was single blinded: the principal investigator was responsible for the assessment of lesions, and the co-investigator was responsible for administration of FLE treatment.
The dogs were assessed over an 8-week period with check-ups every 14 days.
At every check-up the paws treated with FLE showed a greater improvement than paws without FLE treatment.
The lesions were assessed and scored with the global lesion score, the pruritic visual analogue scale, a cytological scoring, and photographic documentation.
The results of the study demonstrated that FLE combined with systemic antibiotics significantly reduced the time to clinical resolution compared to antibiotics alone.
By week four, 50% of paws in the FLE group had reached clinical resolution compared to 17% in the control group.
By week eight, 88% of paws in the FLE group had healed compared to 54% in the control group.
Dr Anja Lange, DVM, Department of Dermatology, AniCura Kleintierspezialisten Augsburg GmbH, Augsburg, Germany, said: “Canine interdigital furunculosis is a challenging condition to treat that can be prolonged and frustrating.
"Having FLE as an additional management tool is very exciting, not least because it speeds up time to healing, but it also requires us to use less antibiotics.
"The use of FLE was well accepted by all of the dog owners from the study and the dogs themselves tolerated it well, showing it can be a very useful adjunct to cases in clinical practice.”
The Recruitment Investment Group (RIG) has established a new recruitment agency that specialises in the supply of skilled professionals to the veterinary animal health market.
The newly formed RIG Animal Health Recruit will be working in the "industry" side of the profession to provide a permanent and temporary recruitment service in areas such as sales, technical product, academia, and laboratory work. The company's activities will not be confined to the UK alone, but, due the nature of this work, it will also operate in Europe.
The new company is headed up by James Roadnight, who has over 14 years' experience in working in specialist recruitment within professional and high integrity industries.
James said: "There comes a time in some vets or vet nurses' careers when they can want a change from working in practice and would like to move their skills to industry or academia. And we can help with this transition. Similarly, companies and institutions have a need to recruit personnel and will benefit from working with an agency that specialises only in this sector and should therefore have the strongest candidates available."
For more information, see www.rigahr.co.uk
Petplan has announced the finalists for the 2013 Petplan Veterinary Awards.
Now in its 14th year, the Petplan Veterinary Awards received its biggest response yet, with 11,000 nominations submitted for exceptional veterinary staff across the UK.
The finalists for each of the categories are:
Vet of the Year
Vet Nurse of the Year
Vet Support Staff of the Year
Vet Practice of the Year
Practice Manager of the Year
Isabella von Mesterhazy, Petplan's Head of Marketing, said: "As the leader in the pet insurance market for over 35 years, we have a rich history of working with veterinary practices across the UK. The Veterinary Awards is a great way to recognise and celebrate the fantastic work that goes on helping keep pets healthy and their owners happy. This year we have seen a near fourfold increase in nominations which goes to show the appetite from both staff and clients for celebrating exceptional work, it is going to be a fantastic night."
Gyles Brandreth will compère the award ceremony on the 4th April at Birmingham Town Hall.
The Heart Health Panel - a group of expert veterinary surgeons, cardiologists and nutritionists set up by Boehringher Ingelheim Vetmedica - has launched a set of guidelines on the management of canine cardiac health through nutrition and lifestyle changes.
Entitled Supporting canine heart health through nutrition and lifestyle, Boehringher says the guidelines provide veterinary professionals with information on canine heart health, including the progression of heart disease through four main stages. These are: the green phase - no clinical signs and no pathology; the yellow phase - no clinical signs of heart failure but evidence of disease at clinical exam; the orange phase - occasional clinical signs when exercising and the red phase - clinical signs at rest.
The panel has developed a diagnostic checklist to determine whether a patient has heart disease and which phase they are in to help initiate a good diet and healthy lifestyle early enough to support heart health. While a dog's individual needs should be taken into account when advising on dietary management and lifestyle, the panel's recommendations include a balanced, complete diet, dietary supplements, such as omega-3, and an appropriate exercise regime.
The Heart Health Panel's guidelines are now available as a booklet and are supported with a leaflet for dog owners entitled Support your dog's heart. The leaflet features information on canine heart health including risk factors, dietary advice, clinical signs of disease, diagnosis and the creation of a heart health management plan. Both the owner leaflet and the panel guidelines are available from Boehringer Ingelheim Vetmedica, and copies can be ordered from your local territory manager or by emailing vetmedica.uk@boehringer-ingelheim.com.
Petsavers, the charitable division of the BSAVA, is calling for entries to its 2012 digital photography competition, this year themed 'Best Buddies'.
The competition is open to entries from pet owners and veterinary professionals alike. The judges will be looking for qualities like humour and character in the photos, as well as photographic skill.
If you need a little inspiration, you can see the winning images from previous years on the BSAVA website.
The competition has two categories: Adult (16 and over) and Junior (under 16). First prize in each category is £200 in photography vouchers, second prize is £100 in photography vouchers and third prize is £50 in photography vouchers. The closing date is Thursday 26 January 2012. To enter the competition, email your photographs to info@petsavers.org.uk. An application form must also be submitted; this can be emailed with your photograph or alternatively you can print and fax the form to BSAVA at 01452 726701.
Petsavers is also encouraging practices to help promote the competition by displaying leaflets in practice, and telling clients about it.
More information is available by emailing: info@petsavers.org.uk or visiting www.petsavers.org.uk/.
The RCVS is to launch a new badge for registered veterinary nurses (RVNs) at the British Veterinary Nursing Association Congress later this week.
The launch ties in with the 50th anniversary of veterinary nurse training, and highlights the fact that RVNs, while qualified to the same level as their listed colleagues, stand apart because they additionally agree to account for their professional practice and keep their skills and knowledge up to date.
The non-statutory RCVS Register of Veterinary Nurses was introduced in 2007, and RVNs abide by a code of professional conduct, commit to continuing professional development and, from 1 April this year, can be taken to task via a disciplinary system.
The new badge builds upon the old version but with the word 'registered' underneath. Plans for a more dramatic departure from the existing badge were dropped when the College saw the affection in which veterinary nurses held the traditional antique silver and red-enamel badge, introduced in 1984.
Liz Branscombe, Chairman of the RCVS Veterinary Nurses Council said: "There is currently no legislation to protect veterinary nurses' title and area of work, but we have not stood still and the Register shows a real commitment to developing our status as professionals. We need to ensure this commitment is recognised by clients and others in the veterinary team, and hope the new badge will make it easier to identify who is professionally accountable."
All those veterinary nurses qualifying since 2003 automatically became registered and those qualifying earlier could choose to do so. Currently there are 8,682 registered veterinary nurses, and 1,463 remain on the unregulated list.
VetSurgeon Jobs has published the results of two surveys designed to give veterinary employers and job applicants some insight into what they want from each other.
The first survey was completed by 139 vets who described themselves as having recently looked for a job, or actively looking for a job, or could imagine looking for a job in the foreseeable future.
Key findings included:
VetSurgeon.org Editor Arlo Guthrie said: "The survey was carried out primarily to help employers create recruitment adverts that better meet the hopes and aspirations of candidates, thereby improving response rates. Whilst some of the conclusions might seem obvious, the report should help you prioritise the things you need to communicate in an advert.
"Of course, employees' hopes and aspirations don't tend to change the moment they get the job (or they shouldn't). So I hope this report will be of interest to ALL veterinary employers, regardless of whether they are actively recruiting."
The candidate survey can be downloaded from VetSurgeon Jobs here ('Advice for Employers' under 'Recruitment Help' in the right hand margin). Come and discuss the findings here.
The second survey was completed by 121 veterinary employers.
By some margin, veterinary employers said that ‘previous experience’ is what makes a CV stand out positively. But there was some solace for the inexperienced. When it comes to the attributes employers are looking for in a candidate, being 'likeable and affable' was reported as being more important than being skilled and experienced.
Respondents were asked to share any tips they have for anyone looking to come and work for them, which are also shared in the full report.
The employer survey can also be downloaded from VetSurgeon Jobs ('Advice for Jobseekers').
Her Royal Highness The Duchess of Cornwall made her first visit to the RVC's Camden campus today, in her role as patron of the College's charity, the Animal Care Trust.
The Duchess became Patron of the Animal Care Trust in 2005, and was visiting to see how funds raised by the charity help to provide cutting edge equipment for the College's hospitals, provide assistance to the College's research teams and support the commitment to excellence in veterinary education.
During the tour of the Beaumont Sainsbury Animal Hospital (BSAH), the Duchess saw how donations from the ACT have helped to purchase laparascopic surgical equipment enabling the hospital to provide key-hole surgery for routine neutering procedures, bringing welfare benefits to the animals and allowing students to develop their first-day skills needed in veterinary practice.
The Duchess also met the specialist exotics team that forms part of a newly launched Small Animals Referral Service based at the BSAH and which receives funding from the ACT.
Professor Stuart Reid, Principal of the RVC, said: "The generous donations to the ACT are invaluable in helping us to deliver the best possible care to our patients and world-leading veterinary education to our students. We were delighted to welcome The Duchess of Cornwall to our teaching hospital in Camden so that she could see just how much of an impact these donations have on the work that we do."
As well as spending time in the hospital the tour also took in the RVC's anatomy museum where the Head of Anatomy Service at the College, Andrew Crook MBE, demonstrated how an investment from the ACT in plastination facilities is helping the College to preserve valuable anatomical samples in a form that can be handled by students without fear of decomposition.
The visit finished with a reception, where supporters and donors of the Trust, as well as some of the College's students had the chance to meet the Duchess.
According to a survey of 2,000 dog owners by Burgess Supadog Sensitive, 18% of women say they speak to their dog more than their partner or husband.
Not only that, but it seems the older you are, the more likely you are to strike up a conversation with the dog: 21 per cent of respondents aged 45-54 said they talked to their dog more than their partner as opposed to 10 per cent of 18-24 year olds.
Other findings from the survey included:
Bimeda has launched Recocam, a 20mg/ml meloxicam preparation licensed for use as a single injection course in cattle, horses and pigs.
Bimeda's Head of Technical Services, Padraig Hyland MVB said: "Meloxicam's anti-inflammatory credentials and safety profile is well proven and it remains rightly popular with large animal vets. With our manufacturing expertise it makes sense to add this widely used product to our portfolio. Our aim is to provide a comprehensive range of both established standards and new innovative products for cattle and equine vets, and this is just another step in that process."
Bimeda says Recocam has a broad range of indications including acute respiratory infections, in combination with oral re-hydration in diarrhoea therapy and acute mastitis, for non-infectious locomotor disorders and lameness in pigs and alleviation of inflammation and pain in both acute and chronic musculo-skeletal disorders and pain relief associated with equine colic. In cattle Recocam can be given by single subcutaneous or intravenous injection.
New statistics from the Voice of the Veterinary Profession Spring 2022 survey showed that while veterinary work is often seen as a vocation, 77% of vets list pay among their top five priorities when choosing a job.
Other deciding factors include geographical location (74%), area of practice (62%), low staff turnover (45%) and structured career progression (28%).
However only 42% of vets who responded to the survey considered their pay and benefits to be either ‘good’, ‘very good’, or ‘excellent’.
BVA President Malcolm Morley, said: “Fair, transparent and equal pay is one of the keystones of good veterinary workplaces.
"Whether you’re an employee, a manager or an employer, it’s vital that everyone feels confident that their workplace approaches pay in a clear and consistent way.
"This isn’t about paying everyone more; it’s about using objective criteria and transparent pay scales to ensure the whole team understands how decisions about reward and recognition are made and what they can do to access higher pay.”
The new resource, created for BVA members as part of its Good Veterinary Workplaces campaign, includes information for veterinary employers on the benefits a clear pay structure can bring for the whole team.
It demonstrates the positive impact transparency around reward and recognition can have on employee fulfilment and retention, and outlines the legal requirements of employers to ensure that pay is equitable.
It also offers tips for employees and managers for approaching conversations about pay and emphasises the importance of considering ‘total reward’ during these conversations.
Total reward is the entire sum of a job’s offering including, but not limited to, salary, commission structure, benefits package, CPD, work/life balance, promotion opportunities, travel expenses, accommodation, and so on.
Malcolm added: “We know that pay can be a fraught, and even somewhat taboo, subject but it is one that we all have a responsibility to tackle if we want to ensure that veterinary professionals are fairly rewarded for their work.
"We hope that this new guide will support all our members and equip them with the knowledge required to ensure they can confidently navigate conversations about pay.”
https://www.bva.co.uk/talking-pay
Registration will start at 9am, with the first lecture from 10am.
As usual, abstracts will be presented during the day, and there's an exhibition to visit during breaks and lunch.
Hot ophthalmology topics such as rhytidectomy and facial reconstruction will be discussed, with lectures presented by renowned veterinary and human ophthalmologists.
The day will end with a Q&A session where all lecturers will take part.
Veterinary surgeons need to be a member of BrAVO to come to the event, which costs £120.
There is a reduced price of £90 for vet students and nurses, who don't have to be a member to attend.
For more information, visit https://bravo.org.uk
The Veterinary Medicines Directorate (VMD) has granted MSD Animal Health a provisional UK marketing authorisation for Bovilis SBV, the first vaccine specifically targeting the Schmallenberg virus (SBV) in cattle and sheep.
SBV, which emerged in late 2011, is transmitted via insect vectors, mainly midges and causes transient clinical symptoms in adult cattle and sheep, such as fever, diarrhoea and reduced milk yield, as well as congenital malformation in newborn calves and lambs. As of March 31st 2013, 1753 cases of SBV had been confirmed throughout the UK. SBV has now been detected in every county in England and Wales.
Andras Bolcskei, Country Manager, MSD Animal Health UK said: "On behalf of Merck MSD, we would like to thank the VMD for its partnership and support to fast track the availability of Bovilis SBV to the market. There was a tremendous urgency for a SBV vaccine in the UK especially given the marked increase in confirmed cases over the past year and the increasing importance to help control this devastating disease."
MSD says that studies it conducted in support of the provisional marketing authorisation showed that all animals responded with formation of virus neutralizing antibodies. During the studies, reduced viraemia against SBV was observed in sheep vaccinated once and prevention of viraemia was observed in cattle vaccinated twice, whereas all animals in the control groups developed infection and became viraemic. In studies to date, Bovilis SBV has been shown to be efficacious in cattle and sheep.
The vaccine is based on wild-type SBV that has been inactivated and contains an adjuvant that stimulates the immune response.
The vaccine will be available in 20ml and 100ml vials. Bovilis SBV is indicated for the active immunisation of cattle to prevent viraemia against SBV and for the active immunisation of sheep to reduce viraemia against SBV.
MSD says it is working diligently to expedite stocks to the UK, and expects Bovilis SBV to arrive in the UK in the coming weeks.
Lanes Health, manufacturer of the mobility supplement, LitoVet, has announced the nominees for the inaugural Litovet Equine Scientific Achievement Award, part of the annual Animal Health Trust (AHT) awards.
The award which has been set up to recognise a person or group whose clinical or scientific work has made a substantial difference to the equine veterinary world will be judged by a panel of leading veterinary surgeons and scientists.
The nominees are:
Peter Clegg - MA VerMB PhD CertsES DepEVCS MRCVS. Dr Clegg is Professor of Equine Surgery and Deputy Head of the Institute of Ageing and Chronic Disease, Faculty of Health and Life Sciences, The University of Liverpool. Peter's current research focus is equine orthopaedics, in particular identifying the basic mechanisms of injury and repair in equine joints and tendons. He has supervised 13 successful PhD students and is currently supervising a further nine.
Andy Durham BSc, BVSc, DEIM, Dipl.ECEIM, MRCVS (RCVS & European Specialist in equine internal medicine). Liphook-based Andy Durham exemplifies the premise that veterinarians in practice can maintain an active interest in current research, undertake clinically relevant research projects, interact with researchers on an international stage and contribute to CPD through scientific papers, book chapters and lectures.
Tim Mair BVSc PhD DEIM DESTS DipECEIM MRCVS. Dr Mair ha been innovative in veterinary practice (e.g., an early adopter of standing magnetic resonance imaging [MRI]), has an extensive publication list recently focusing on evidence-based medicine for colic, but spanning the full breadth of common medical disorders in horses. He has made an enormous contribution to veterinary practice within both Europe and America in his role as Editor of Equine Veterinary Education.
Chris Proudman MA VetMB PhD CertEO FRCVS.Dr Proudman is Professor of Equine Studies at the University of Liverpool. His research interests are related to the aetiology and surgical management of acute intestinal disease (colic) in the horse: specifically, the diagnosis of intestinal parasites associated with colic and understanding dietary determinants of colic. Most recently this has involved using metabolomics and molecular microbiology to investigating the intestinal microbiota and its response to dietary change.
The LitoVet Equine Scientific Achievement Award can be granted to any individual or group that is currently undertaking, or has successfully implemented within the past ten years, one or more clinical or other research projects which has, or will, make a significant contribution to equine health and welfare.
The award will be presented to the recipient, or recipients, at the UK Equestrian Awards held at the Lancaster London on Thursday 3 November 2011.
Merial has launched a limited trial pack version of Equioxx® (firocoxib), the company's COX-2 specific NSAID for horses, which contains 10 tubes of the oral paste.
According to the company, Equioxx is the only equine NSAID that is highly COX-2 selective, acting to reduce pain and inflammation whilst preserving the natural physiological effects of the COX-1 enzyme, at therapeutic levels.
The company also claims that field studies have confirmed that firocoxib is highly effective at controlling pain and improving function in horses with chronic osteoarthritis.
Jim Tipp BVSc MRCVS, partner at Shropshire based Fyrnwy Equine Clinics said: "As a COX-2 specific NSAID it is not only a good analgesic, but is also an excellent anti-inflammatory. In addition, the COX-1 sparing properties of Equioxx are beneficial where there is increased risk of ulceration."
Equioxx is also available as a low dose injectable solution. For more information contact Merial Customer Services on 0870 6000 123.